Fundraising FoxMetispharma
1 known investors
Find your way into Metispharma
Sign up to see every warm intro you have to Metispharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Metispharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Metis Pharma is an AI-driven biotech company focused on nanomaterial innovation for targeted drug delivery and discovery, developing therapies for oncology, metabolic diseases, autoimmune disorders, and neurodegenerative conditions. The company has developed three core AI platforms: AiLNP for nanoparticle design, AiRNA for mRNA sequence design, and AiTEM for small molecule formulation.
Founders & leadership
陈(
陈红敏 (Hong-Min Chen)Co-founder
赖(
赖才达 (Cai-Da Lai)Co-founder
王(
王文首 (Wen-Shou Wang)Co-founder
Investors · 1
Source Code Capitallisted by Source Code CapitalBeijing
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Metispharma do?
- Metis Pharma is an AI-driven biotech company focused on nanomaterial innovation for targeted drug delivery and discovery, developing therapies for oncology, metabolic diseases, autoimmune disorders, and neurodegenerative conditions. The company has developed three core AI platforms: AiLNP for nanoparticle design, AiRNA for mRNA sequence design, and AiTEM for small molecule formulation.
- Who founded Metispharma?
- Metispharma was founded by 陈红敏 (Hong-Min Chen), 赖才达 (Cai-Da Lai), 王文首 (Wen-Shou Wang).
- Who are Metispharma's investors?
- Metispharma's investors include Source Code Capital.